Engineering the brain tumor microenvironment enhances the efficacy of dendritic cell vaccination: implications for clinical trial design. Jul 2011 - Clin. Cancer Res.; 17(14):1078-0432 [PMID:21632862] [Mineharu Y] [King GD] [Muhammad AG] [Bannykh S] [Kroeger KM] [Liu C] [Lowenstein PR] [Castro MG]
